VSee Health, Inc. (VSEEW) 10-Year Financial Performance & Capital Metrics

VSEEW • • Industrial / General

HealthcareHealthcare ITTelehealth & Virtual Care PlatformsSpecialized Telehealth Solutions

AboutVSee Health, Inc. provides telehealth care solutions. The company offers iDoc Telehealth solutions that treat and coordinate care for acutely ill patients in the neurointensive care, cardiac intensive care, and intensive care units for stroke, spinal cord, brain trauma, and other neurological conditions. Its telehealth platform provides a set of building blocks to solve needs of clients. VSee Health, Inc. is headquartered in Newton, Massachusetts.Show more

Revenue $10M +78.4%
EBITDA -$61M -4030.6%
Net Income -$58M -1573.4%
EPS (Diluted) -5.65 -572.6%
Gross Margin 68.87% +2.9%
EBITDA Margin -583.15% -2215.1%
Operating Margin -596.38% -2266.5%
Net Margin -553.69% -837.9%
ROE -
ROIC -1500.09%
Debt/Equity -
Interest Coverage -293.91 -43395.3%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Momentum leader: RS Rating 90 (top 10%)

✗Weaknesses

✗Weak Piotroski F-Score: 3/9
✗Negative free cash flow
✗Low quality earnings: Net income not backed by cash flow
✗Shares diluted 100.0% in last year
✗Trading more than 30% below 52-week high

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-

5Y-

3Y12.41%

TTM80.43%

Profit (Net Income) CAGR

10Y-

5Y-

3Y-

TTM77.12%

EPS CAGR

10Y-

5Y-

3Y-

TTM92.96%

ROCE

10Y Avg-1752.34%

5Y Avg-1752.34%

3Y Avg-3554%

Latest-6327.92%

Peer Comparison

Specialized Telehealth Solutions

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
VSEEWVSee Health, Inc.	1.52M	0.09	-0.02	78.42%	-85.76%
VSEEVSee Health, Inc.	14.7M	0.44	-0.08	80.74%	-85.76%
MGRXMangoceuticals, Inc.	10.82M	0.66	-0.15	-15.81%	-42.45%	-126.03%		0.02
BEATHeartBeam, Inc.	75.78M	2.20	-3.01			-50.79%
OMDAOmada Health	906.26M	15.65	-18.41	38.29%	-16.82%	-16.98%		0.47
HNGEHinge Health, Inc.	1.66B	43.76	-291.73	33.37%	-3.06%	-2.83%	2.73%	0.03

Profit & Loss

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	6.8M	7.34M	6.38M	5.84M	10.42M
Revenue Growth %	-	0.08%	-0.13%	-0.08%	0.78%
Cost of Goods Sold+	1.34M	1.41M	1.54M	1.93M	3.24M
COGS % of Revenue	0.2%	0.19%	0.24%	0.33%	0.31%
Gross Profit+	5.46M	5.92M	4.84M	3.91M	7.18M
Gross Margin %	0.8%	0.81%	0.76%	0.67%	0.69%
Gross Profit Growth %	-	0.08%	-0.18%	-0.19%	0.84%
Operating Expenses+	5.06M	5.67M	3.59M	5.47M	69.33M
OpEx % of Revenue	0.74%	0.77%	0.56%	0.94%	6.65%
Selling, General & Admin	5.06M	5.67M	3.59M	5.38M	11.86M
SG&A % of Revenue	0.74%	0.77%	0.56%	0.92%	1.14%
Research & Development	0	0	0	0	0
R&D % of Revenue	-	-	-	-	-
Other Operating Expenses	0	0	156.52K	86.8K	57.47M
Operating Income+	404.5K	252.28K	-3.59M	-1.47M	-62.15M
Operating Margin %	0.06%	0.03%	-0.56%	-0.25%	-5.96%
Operating Income Growth %	-	-0.38%	-15.25%	0.59%	-41.22%
EBITDA+	0	0	-2.13M	-1.47M	-60.77M
EBITDA Margin %	-	-	-0.33%	-0.25%	-5.83%
EBITDA Growth %	-	-	-	0.31%	-40.31%
D&A (Non-Cash Add-back)	-404.5K	-252.28K	1.46M	678	1.38M
EBIT	404.5K	252.28K	-2.93M	-2.24M	-59.13M
Net Interest Income+	45.03K	0	-31.87K	-1.82M	-211.46K
Interest Income	45.03K	0	0	358.77K	0
Interest Expense	0	0	31.87K	2.18M	211.46K
Other Income/Expense	-45.03K	134.06K	59.92K	-100.17K	2.81M
Pretax Income+	359.47K	386.34K	-3.06M	-1.57M	-59.34M
Pretax Margin %	0.05%	0.05%	-0.48%	-0.27%	-5.69%
Income Tax+	100.59K	108.11K	187.22K	1.84M	-1.64M
Effective Tax Rate %	0.72%	1.23%	1.06%	2.19%	0.97%
Net Income+	258.88K	475.9K	-3.24M	-3.45M	-57.7M
Net Margin %	0.04%	0.06%	-0.51%	-0.59%	-5.54%
Net Income Growth %	-	0.84%	-7.81%	-0.06%	-15.73%
Net Income (Continuing)	258.88K	278.23K	-3.24M	-4.41M	-57.7M
Discontinued Operations	0	0	0	37.48K	0
Minority Interest	0	-273.21K	-362.75K	-325.28K	0
EPS (Diluted)+	0.02	-0.02	-0.25	-0.84	-5.65
EPS Growth %	-	-2.09%	-12.3%	-2.36%	-5.73%
EPS (Basic)	0.02	-0.02	-0.25	-0.84	-5.65
Diluted Shares Outstanding	14.93M	14.93M	12.74M	4.12M	10.21M
Basic Shares Outstanding	14.93M	14.93M	12.74M	4.12M	10.21M
Dividend Payout Ratio	-	-	-	-	-

Balance Sheet

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	1.48M	777.75K	759.78K	827.13K	3.02M
Cash & Short-Term Investments	775.24K	346.44K	230.66K	118.73K	326.12K
Cash Only	775.24K	346.44K	230.66K	118.73K	326.12K
Short-Term Investments	0	0	0	0	0
Accounts Receivable	659.04K	286.09K	389.45K	628.48K	2.25M
Days Sales Outstanding	35.35	14.23	22.29	39.27	78.74
Inventory	0	0	0	0	0
Days Inventory Outstanding	-	-	-	-	-
Other Current Assets	0	145.22K	0	0	446.83K
Total Non-Current Assets+	1.25M	1.16M	1.85M	3.66K	16.97M
Property, Plant & Equipment	0	0	0	3.66K	1.06M
Fixed Asset Turnover	-	-	-	1597.18x	9.83x
Goodwill	0	0	0	0	4.92M
Intangible Assets	0	0	0	0	10.99M
Long-Term Investments	0	0	0	0	0
Other Non-Current Assets	1.25M	0	1.85M	0	0
Total Assets+	2.73M	1.94M	2.61M	830.79K	19.99M
Asset Turnover	2.50x	3.79x	2.44x	7.03x	0.52x
Asset Growth %	-	-0.29%	0.35%	-0.68%	23.06%
Total Current Liabilities+	2.11M	1.01M	2.61M	4.24M	19.01M
Accounts Payable	311.24K	202.45K	687.82K	187.22K	4.28M
Days Payables Outstanding	84.75	52.28	162.74	35.35	481.98
Short-Term Debt	133.08K	0	517.13K	543K	8.28M
Deferred Revenue (Current)	0	810.05K	0	0	417.81K
Other Current Liabilities	1.67M	0	1.23M	2M	2.51M
Current Ratio	0.70x	0.77x	0.29x	0.19x	0.16x
Quick Ratio	0.70x	0.77x	0.29x	0.19x	0.16x
Cash Conversion Cycle	-	-	-	-	-
Total Non-Current Liabilities+	0	0	0	4.37M	1M
Long-Term Debt	0	0	0	0	0
Capital Lease Obligations	0	0	0	0	863.28K
Deferred Tax Liabilities	0	0	0	0	67.38K
Other Non-Current Liabilities	0	0	0	4.37M	0
Total Liabilities	2.11M	1.01M	2.61M	4.24M	20.01M
Total Debt+	133.08K	0	517.13K	543K	9.55M
Net Debt	-642.16K	-346.44K	286.47K	424.27K	9.22M
Debt / Equity	0.22x	-	-	-	-
Debt / EBITDA	-	-	-	-	-
Net Debt / EBITDA	-	-	-	-	-
Interest Coverage	-	-	-112.81x	-0.68x	-293.91x
Total Equity+	614.49K	923.72K	-2.03K	-3.41M	-18.49K
Equity Growth %	-	0.5%	-1%	-1677.63%	0.99%
Book Value per Share	0.04	0.06	-0.00	-0.83	-0.00
Total Shareholders' Equity	614.49K	1.2M	360.72K	-3.09M	-18.49K
Common Stock	985	1K	1K	1K	1.63K
Retained Earnings	-5.38M	-4.83M	-5.67M	-9.11M	-67.7M
Treasury Stock	0	0	0	0	0
Accumulated OCI	0	0	0	0	0
Minority Interest	0	-273.21K	-362.75K	-325.28K	0

Cash Flow

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	789.12K	-600.11K	-1.45M	-632.6K	-5.79M
Operating CF Margin %	0.12%	-0.08%	-0.23%	-0.11%	-0.56%
Operating CF Growth %	-	-1.76%	-1.42%	0.56%	-8.15%
Net Income	258.88K	-280.7K	-3.24M	-3.73M	-57.7M
Depreciation & Amortization	0	0	0	678	1.38M
Stock-Based Compensation	0	0	0	0	896.54K
Deferred Taxes	0	0	0	1.85M	-1.68M
Other Non-Cash Items	1.16M	-1.97K	-727.47K	-71.87K	54.52M
Working Capital Changes	-629.07K	-317.44K	2.52M	1.31M	-3.21M
Change in Receivables	-604.06K	0	0	-246.48K	-839.81K
Change in Inventory	0	0	0	0	0
Change in Payables	0	0	0	1.41M	-1.45M
Cash from Investing+	0	-116.73M	110.12M	-4.33K	-26.14K
Capital Expenditures	0	0	0	-4.33K	-55.27K
CapEx % of Revenue	-	0%	0%	0%	0.01%
Acquisitions	-	-	-	-	-
Investments	-	-	-	-	-
Other Investing	0	0	110.47M	0	0
Cash from Financing+	-83.67K	118.09M	-109.32M	525K	6.02M
Debt Issued (Net)	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-
Dividends Paid	0	0	0	0	0
Share Repurchases	-	-	-	-	-
Other Financing	-83.67K	118.66M	0	135K	1.27M
Net Change in Cash	-	-	-	-	-
Free Cash Flow+	789.12K	-600.11K	-1.45M	-636.93K	-5.84M
FCF Margin %	0.12%	-0.08%	-0.23%	-0.11%	-0.56%
FCF Growth %	-	-1.76%	-1.42%	0.56%	-8.18%
FCF per Share	0.05	-0.04	-0.11	-0.15	-0.57
FCF Conversion (FCF/Net Income)	3.05x	-1.26x	0.45x	0.18x	0.10x
Interest Paid	0	0	0	0	111.33K
Taxes Paid	0	0	0	0	0

Key Ratios

Metric	2020	2021	2022	2023	2024
Return on Equity (ROE)	42.13%	61.88%	-703.6%	-	-
Return on Invested Capital (ROIC)	-	68.85%	-625.78%	-	-1500.09%
Gross Margin	80.3%	80.74%	75.81%	66.9%	68.87%
Net Margin	3.8%	6.49%	-50.84%	-59.03%	-553.69%
Debt / Equity	0.22x	-	-	-	-
Interest Coverage	-	-	-112.81x	-0.68x	-293.91x
FCF Conversion	3.05x	-1.26x	0.45x	0.18x	0.10x
Revenue Growth	-	7.82%	-13.08%	-8.42%	78.42%

Revenue by Segment

	2024
Subscription and Circulation	4.12M
Subscription and Circulation Growth	-
Technology Service	1.98M
Technology Service Growth	-
Health Care, Patient Service	1.21M
Health Care, Patient Service Growth	-

Frequently Asked Questions

Growth & Financials

VSee Health, Inc. (VSEEW) reported $14.6M in revenue for fiscal year 2024. This represents a 114% increase from $6.8M in 2020.

VSee Health, Inc. (VSEEW) grew revenue by 78.4% over the past year. This is strong growth.

VSee Health, Inc. (VSEEW) reported a net loss of $12.5M for fiscal year 2024.

Dividend & Returns

VSee Health, Inc. (VSEEW) had negative free cash flow of $4.5M in fiscal year 2024, likely due to heavy capital investments.

← Back to Screener